Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 3,964,447,600
  • Market Capitalization, $K 3,964,448
  • Shares Outstanding, K 47,450
  • 60-Month Beta 1.67
  • Price/Earnings ttm 17.55
  • Annual Dividend & Yield 0.09 (0.10%)
  • Most Recent Dividend 0.012 on 12/21/18
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.87 +6.32%
on 09/04/19
84.12 -1.58%
on 09/16/19
+0.33 (+0.40%)
since 08/16/19
3-Month
77.87 +6.32%
on 09/04/19
89.30 -7.29%
on 07/01/19
-4.17 (-4.80%)
since 06/18/19
52-Week
64.38 +28.60%
on 12/24/18
97.60 -15.17%
on 09/26/18
-12.66 (-13.26%)
since 09/18/18

Most Recent Stories

More News
Top-Performing Biotech ETFs YTD

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

CELG : 98.67 (+0.07%)
ILMN : 303.01 (+1.59%)
BBH : 122.33 (-0.63%)
RHHBY : 35.2900 (+0.31%)
AMGN : 195.04 (-0.85%)
BMY : 49.86 (+0.24%)
BTEC : 33.30 (+0.49%)
SBIO : 35.83 (-0.99%)
ARKG : 32.00 (+0.07%)
GILD : 65.72 (-0.68%)
GLPG : 158.11 (-0.84%)
XBI : 82.79 (-0.93%)
EC : 17.69 (-0.45%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 50.07 (-0.80%)
IBB : 104.44 (-0.71%)
VRTX : 174.52 (-0.84%)
INCY : 78.54 (-0.71%)
AMGN : 195.04 (-0.85%)
XBI : 82.79 (-0.93%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

TECH : 198.41 (+0.37%)
PBE : 50.07 (-0.80%)
IBB : 104.44 (-0.71%)
AMGN : 195.04 (-0.85%)
XBI : 82.79 (-0.93%)
BIIB : 235.17 (-1.48%)
Biotech ETFs in Focus on Impressive Q2 Earnings Results

Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q2 earnings results recently.

IBB : 104.44 (-0.71%)
FBT : 130.84 (-0.73%)
BBH : 122.33 (-0.63%)
GILD : 65.72 (-0.68%)
AMGN : 195.04 (-0.85%)
XBI : 82.79 (-0.93%)
ALXN : 102.98 (-4.50%)
BIIB : 235.17 (-1.48%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

TECH : 198.41 (+0.37%)
PBE : 50.07 (-0.80%)
IBB : 104.44 (-0.71%)
INCY : 78.54 (-0.71%)
AMGN : 195.04 (-0.85%)
XBI : 82.79 (-0.93%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 50.07 (-0.80%)
CELG : 98.67 (+0.07%)
ILMN : 303.01 (+1.59%)
IBB : 104.44 (-0.71%)
QGEN : 34.04 (-0.26%)
XBI : 82.79 (-0.93%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 50.07 (-0.80%)
CELG : 98.67 (+0.07%)
ILMN : 303.01 (+1.59%)
ALNY : 85.49 (-2.65%)
FBT : 130.84 (-0.73%)
XBI : 82.79 (-0.93%)
S&P 500 Hit New Records: Buy These High-Beta ETFs & Stocks

High-beta ETFs & stocks seek to capitalize on continued growth with market-beating returns.

RNGR : 6.47 (-0.77%)
PTF : 72.20 (-0.40%)
KO : 54.23 (-0.02%)
TWTR : 43.24 (unch)
VTWG : 146.13 (-0.73%)
PXMG : 59.49 (-1.10%)
OMF : 37.49 (-1.03%)
FXZ : 37.68 (-0.55%)
DXPE : 36.51 (+0.38%)
AVID : 6.30 (-1.25%)
LMT : 397.04 (+0.78%)
UTX : 137.66 (+0.33%)
NCR : 33.61 (+2.25%)
XBI : 82.79 (-0.93%)
S&P 500 Hit New Records: Buy These High-Beta ETFs & Stocks

High-beta ETFs & stocks seek to capitalize on continued growth with market-beating returns.

RNGR : 6.47 (-0.77%)
PTF : 72.20 (-0.40%)
KO : 54.23 (-0.02%)
TWTR : 43.24 (unch)
VTWG : 146.13 (-0.73%)
PXMG : 59.49 (-1.10%)
OMF : 37.49 (-1.03%)
FXZ : 37.68 (-0.55%)
DXPE : 36.51 (+0.38%)
AVID : 6.30 (-1.25%)
LMT : 397.04 (+0.78%)
UTX : 137.66 (+0.33%)
NCR : 33.61 (+2.25%)
XBI : 82.79 (-0.93%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 50.07 (-0.80%)
CELG : 98.67 (+0.07%)
ILMN : 303.01 (+1.59%)
IBB : 104.44 (-0.71%)
ALNY : 85.49 (-2.65%)
XBI : 82.79 (-0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade XBI with:

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 84.51
1st Resistance Point 83.65
Last Price 82.79
1st Support Level 81.83
2nd Support Level 80.87

See More

52-Week High 97.60
Fibonacci 61.8% 84.91
Last Price 82.79
Fibonacci 50% 80.99
Fibonacci 38.2% 77.07
52-Week Low 64.38

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar